4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-057633
Director sold 32,743 shares at an average $50.28 ($1,646,251)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prokupets Elena Director | 2021-09-22 | Sale | −3,544 | $50.10 | $177,554 | 39,492 | I |
| Prokupets Elena Director | 2021-09-22 | Sale | −7,004 | $50.09 | $350,860 | 519,360 | I |
| Prokupets Elena Director | 2021-09-23 | Sale | −5,926 | $50.35 | $298,359 | 33,566 | I |
| Prokupets Elena Director | 2021-09-23 | Sale | −446 | $51.09 | $22,784 | 33,120 | I |
| Prokupets Elena Director | 2021-09-23 | Sale | −11,801 | $50.35 | $594,193 | 507,559 | I |
| Prokupets Elena Director | 2021-09-23 | Sale | −1,007 | $51.08 | $51,435 | 506,552 | I |
| Prokupets Elena Director | 2021-09-24 | Sale | −900 | $50.11 | $45,101 | 32,220 | I |
| Prokupets Elena Director | 2021-09-24 | Sale | −2,115 | $50.10 | $105,964 | 504,437 | I |
| Open-market sales · 32,743 sh · avg $50.28 · $1,646,251 | |||||||
Loading xslF345X03/doc4.xml…